StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/7.5mg Tablet
Marketer
Sarvagunaushdhi Pvt Ltd
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (7.5mg)
Overview StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/7.5mg Tablet
DiaControl, a combined Glimepiride (2mg), Metformin (500mg), and Pioglitazone (7.5mg) tablet, effectively manages blood glucose. This medication, used alongside diet and exercise, enhances blood sugar regulation in adult patients with type 2 diabetes. It improves insulin efficiency, thus reducing blood sugar. Always adhere to your physician's prescribed dosage and regimen. Take DiaControl with food to prevent digestive discomfort. If a dose is missed, take it promptly; however, if the next dose is imminent, omit the missed dose and resume your regular schedule. Never double the dose; overdose can cause dangerously low blood sugar (hypoglycemia). Concurrent use with other diabetes medications, alcohol, or skipped meals may trigger hypoglycemia. Regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, inform your doctor about any kidney, liver, or heart conditions. Pregnant or lactating individuals must consult their doctor before use. Kidney function tests will be conducted before treatment begins. Limit alcohol consumption, as it may exacerbate side effects.
Uses of StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/7.5mg Tablet
Managing Type 2 diabetes
Major Benefits of StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/7.5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/7.5mg tablets with food.
Common Side effects of StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/7.5mg Tablet:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/7.5mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to the specified dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/7.5mg Tablet should be administered with a meal.
How StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/7.5mg Tablet works:
StayHappi tablets, containing Glimepiride 2mg, Metformin 500mg, and Pioglitazone 7.5mg, combine three distinct antidiabetic agents for enhanced blood sugar management. This triple therapy is indicated when single or dual medications prove insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood glucose levels. Metformin, a biguanide, acts through multiple pathways: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, complements this action by further enhancing insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/7.5mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/7.5mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing this medication. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/7.5mg tablets while breastfeeding is likely inadvisable. Available evidence in humans indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
The combination medication, StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/7.5mg Tablet, requires careful consideration in individuals with kidney impairment. Dosage modifications may be necessary. Physician consultation is recommended. In patients experiencing severe kidney disease, this medication is contraindicated. Routine monitoring of kidney function is advised during treatment.
LiverCAUTION
Patients with liver impairment should use StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/7.5mg tablets cautiously, potentially requiring dosage modification. Consult a physician before use. This medication is contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/7.5mg Tablet :
Should you forget a dose of StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/7.5mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About StayHappi Glimepiride+Metformin+Pioglitazone 2mg/500mg/7.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently